Global Cannabis Applications Corp (APP)

[HighYieldStocks]

https://twitter.com/CitizenGreenWld/status/1352179915744038913

[HighYieldStocks]

Looks like a buyout is coming sooner or later...MASSIVE

[HighYieldStocks]

Yeah, and the Alqami Co-founder and CEO, Samantha Campbell, commented “The medical cannabis market is growing rapidly across the globe. The ability to determine efficacy of specific strains and track those from seed to application is an area that has not yet been utilised by the investment management community. We look forward to working with GCAC to help fill this information market gap.”

[HighYieldStocks]

Wow, massive news ... "GCAC Signs Data Sales Contract For Medical Cannabis Data" (Jan.20, 2021) ... GCAC has signed a definitive Data Sales Service Agreement with Alqami. The partnership will enable GCAC to leverage Alqami’s global buyer network. Company expects Efixii data license revenue to almost double its per-gram income.

https://www.thenewswire.com/archives/1ArbFxXzz

[HighYieldStocks]

Loaded more today for a reason! Blast-Off is imminent!! Quarter Plus!! Mark my words. Just load and lock up your shares before too late.

$APP

[HighYieldStocks]

Overall Average: 100% BUY ... https://www.barchart.com/stocks/quotes/FUAPF/opinion

[HighYieldStocks]

Holy Moly, new 3Y high ... weeeee !!!!

[HighYieldStocks]

Undiscovered gem ... holy shit, huge potential ... going to thrill investors !!!!!!!

[HighYieldStocks]

I feel very secure with my investment here, global cannabis. we have great investors who know how to hold their shares, sometimes I see desperate people selling 5 thousand shares 1 cent below the price. but in the end the price goes up. who sells below the price will come back buying more expensive. maybe i'm a dreamer but i see potential for 1 dollar /share soon. but this time we not fall back. we will keep going up up up, great potential here. After .25 lot of volume comes . ??????

Alot of loyal share holders who all agree that not a single share will be sold for less than a dollar. With what I am sure is many deals in the pipeline the next few months will be very exciting. We only half of our fair market value of 38 cents per share

There will always be some weak hands, and that's okay, but the smart money will hold this well beyond $1, IMO, meaning really big investors will certainly do that, because they know the tremendous potential for this company at this stage.
Just talked to one very conservative seasoned investor yesterday, and he just bought a huge stake in GCAC and he's in the process of upping it and he's talking about $5/share based on his analysis (and it's reasonable). There's lots in the works for GCAC as things have been established now on a broad scale. It's not just the revenue model for Efixii, but with the Citizen Green universe there's much more that will evolve, IMO, in the coming months and throughout the year. It will be fun to be an investor here I think.

[HighYieldStocks]

I'm finally excited about this stock again!

Global Cannabis Closes Private Placement
Vancouver, British Columbia, Canada, January 7, 2021 – Global Cannabis Applications Corp.(“GCAC” or the “Company”) (CSE: APP, FSE: 2FA), a leading developer of innovative data technologies for the medical cannabis industry, announces it has closed its non- brokered private placement (the “Private Placement”).


technically (with paperwork, etc.) it just closed now. It is putting more liquidity into the company to do what it is doing. BTW, all shares and warrants from Private Placements are restricted which means these investors can't sell for at least 4 months from when the PP closes. Usually all of these large investors are long-term investors.

[HighYieldStocks]

Higher gainz based on higher highs...slap it, friends of APP/FUAPF

[HighYieldStocks]

FUAPF/APP Newest Morningstar rating (Jan.7, 2021) mit Fair Value of CDN$0.38 and still "Undervalued" ... a picture is worth a thousand words ?? ... Also with recent listing in key cannabis stocks on SeekingAlpha, GCAC is gaining broad industry acceptance.

[HighYieldStocks]

What's the catalysts here that will drive it 100x higher? Take a look

High-profit margin revenue and exponential growth with virtually a "monopoly" with this business model and this app. Also valuation of course, as FUAPF/APP has only 1% the valuation of the initial valuation of the SSPK/Weedmaps merger, that alone is 100x opportunity, but there's much more to it as the Weedmaps valuation will increase and FUAPF/APP will automatically follow to the upside, IMO, and of course the global expansion of the Citizen Green universe with Efixii etc.

The 128 million grams by 2023 with expected high-margin revenue of CDN$0.38 per is only a fraction of the global cannabis market, which will expand tremendously when cannabis prohibition will end in the USA very soon, followed by many other countries around the world.

There are a lot more other things that are integrated in GCAC which have the potential produce tremendous revenue and cashflow, and there's always the buyout potential of course as GCAC is uniquely positioned in the global marketplace with everything (infrastructure) that GCAC has built over the past couple of years.

[HighYieldStocks]

As we said here over and over again for weeks, the hottest cannabis stock FUAPF/APP up again over +46% to over US$0.155 ... it's the ultimate pick-and-shovel play of the industry at only approx. 1% of valuation (approx. $15 Million) of SSPK/Weedmaps merger initial valuation ($1.5 Billion). So there's a 100x opportunity, IMO. And FUAPF is just getting started with recent news of CDN$0.38 per gram for their Efixii efficacy app QR code application on 128 million grams by 2023. Apparently lots of institutional interest here as this high-growth company's stock has been stair-stepping its way up over +1,200% in the past 4 months.
#cannabis #stocks #profits #GCAC #FUAPF #APP #investments

[HighYieldStocks]

CNSX:APP filings right here... https://www.thecse.com/en/trading/market-activity/company-filings

[HighYieldStocks]

https://www.transparent-c.io/

https://cannappscorp.com/2021/01/04/gcac-signs-definitive-reseller-agreement-for-efixii-into-233-million-israeli-medical-cannabis-market/

[HighYieldStocks]

With today's news for FUAPF here's the website of its new Reseller Transparent-C ( transparent-c.io/ ) in Israel for its Citizen Green Efixii (“Efixii”) Reseller & License Agreement. The homepage also features prominently the Efixii video

.

This is serious stuff fellow investors and traders, and it's just the beginning of tremendous growth for FUAPF - GCAC (Global Cannabis Applications Corp), IMO.

#stocks #cannabis #growth #GCAC #FUAPF #APP #efficacy #Israel

[HighYieldStocks]

BIG NEWS OUT... $FUAPF "Signs Definitive Reseller Agreement for Efixii into $233 Million Israeli Medical Cannabis Market" ...

Brad Moore, CEO of GCAC said, “Our revenue model of Efixii licensing plus data sales generates CDN$.38/ gram for us. As such this reseller agreement into Israel with it growing consumer bases will be a big part of GCAC achieving its first and second year sales targets." FUAPF's Efixii continues to generate significant interest amongst Israeli growers as a means to reduce the cost of both grow and export compliance. The nascent Israeli medical cannabis market is currently valued at $233 million annually. The big cash cow for FUAPF is the CDN$0.38 per gram expecting 128 million grams with Efixii's QR code in the coming years as stated in recent news.

https://cannappscorp.com/2021/01/04/gcac-signs-definitive-reseller-agreement-for-efixii-into-233-million-israeli-medical-cannabis-market/(https://cannappscorp.com/2021/01/04/gcac-signs-definitive-reseller-agreement-for-efixii-into-233-million-israeli-medical-cannabis-market/)

[HighYieldStocks]

"Indirect" Bitcoin plays are making a fortune and are prone to rise substantially. With Bitcoin hitting over $33,000 over the weekend (currently at $31,200), it's a given that FUAPF/APP is going to be big in crypto, and not just in Bitcoin. FUAPF's SaaS for medical cannabis is a game changer.

Associated Abbey Technology is big in the crypto space with support of Bitcoin, Ethereum and Litecoin. The first cannabis efficacy rewards service that FUAPF integrates with is talketh.io which is a crypto-telco. For even a much higher boost, perhaps FUAPF's balance sheet should be in Bitcoin just like MSTR (MicroStrategy) which has been soaring over +300% from below the $100 low in March to now over $400/share this AM.

Considering this fact alone, FUAPF remains extremely undervalued and will most likely run to around $0.30-$0.50 or so in the coming weeks.
#Bitcoin #Litecoin #Ethereum #stocks #GCAC #APP #FUAPF

[HighYieldStocks]

Expecting a whole lot more action to come here... GCAC CEO Brad Moore's update post from today (12/31/2020):
https://www.linkedin.com/posts/activity-6750556090175504384-zznj/
Global Cannabis (APP:CNX) News and Media (ref)
733% Return in 106 days. An amazing 4th quarter results from an amazing team & shareholders.
Dec 18/20, 9:45 AM- Global Cannabis reaches new 52-Week High ** $0.125
Dec 17/2020, 9:45 AM- Global Cannabis reaches new 52-Week High
Dec 16/20, 9:58 AM- Global Cannabis reaches new 52-Week High
Dec 15/2020, 8:12 AM- GCAC Announces Commercial Launch of Medical Cannabis Efficacy App
Dec 1/20,8:12 AM- GCAC Outlines Its Ethereum 2.0 Roadmap for Medical Cannabis
Nov 11/20, 9:45 AM- Global Cannabis reaches new 52-Week High

Nov 10/20,
9:45 AM- Global Cannabis reaches new 52-Week High
8:11 AM- GCAC Enters into Definitive Agreement with Purity-IQ Biotechnology
Nov 9/20, 9:45AM- Global Cannabis reaches new 52-Week High
Oct 29/20, 8:10- AM GCAC Announces End-to-End SaaS Licensing for All Medical Cannabis Lifecycle Participants
Oct 20/20, 9:45- AM Global Cannabis reaches new 52-Week High
Oct 19/20, 1:30 PM- Global [#Cannabis](https://www.linkedin.com/feed/hashtag/?keywords=cannabis&highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6750556090175504384) reaches new 52-Week High
Oct 16/20, 12:37 PM- Global Cannabis reaches new 52-Week High
Oct 14/20, 8:10 AM- Citizen Green Medical Cannabis Data-Acquisition Platform Goes Live with Signing of a 3-Year SaaS Licensing Deal
Oct 5/20, 8:10 AM- GCAC Strengthens [#MedicalCannabis](https://www.linkedin.com/feed/hashtag/?keywords=medicalcannabis&highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6750556090175504384) Efficacy Platform with Purity
[#tesla](https://www.linkedin.com/feed/hashtag/?keywords=tesla&highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6750556090175504384) [#bitcoin](https://www.linkedin.com/feed/hashtag/?keywords=bitcoin&highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6750556090175504384)

[HighYieldStocks]

A great read: Brand New exciting Investor Deck from #GCAC ( $FUAPF) complete with all the details and info re: #technology in the #cannabis industry. https://t.co/kQbjaTK5Gv

$fuapf @CitizenGreenWld This could be a nice fit with $grnf and $hpst @hempstractlabs #cbd #cannabis business. @IncGrn

$FUAP watch the video. Nice ???? https://t.co/MXpJgLgWcA

https://stockcharts.com/h-sc/ui?s=FUAPF&p=D&b=5&g=0&id=p77706984513

[HighYieldStocks]

GCAC MUST READ...we are good here

GCAC (Global Cannabis Apps Corp, USA: FUAPF / Canada: APP). An interesting news item is that the largest GCAC shareholder directly involved with GCAC, Brian Collins (CEO of Horizon Fintex and the new Upstream Stock Exchange) just announced the "Horizon and MERJ announce 'Upstream', the First Global Exchange for Crowdfunded Securities"...

Just a thought: It's a possibility that thousands of smaller cannabis companies (like growers, distributors/dispensaries) from around the world could potentially list/IPO their shares on the Upstream Stock Exchange with FUAPF's Efixii App chain-of-custody truths as the mandatory "Compliance" tool

https://www.accesswire.com/620908/Horizon-and-MERJ-announce-Upstream-the-First-Global-Exchange-for-Crowdfunded-Securities

Bottom line: Although very good performance of FUAPF in recent months, the company is still extremely undervalued, IMO, with a market cap of less than $15 Million compared to the SSPK/Weedmaps merger valuation of initially $1.5 Billion. So at least a +10,000% upside (stock price of US$8-$10/share from currently US$0.09), IMO, for FUAPF in the coming years.

#stocks #investments #cannabis #growth #Weedmaps #technology #crowdfunding #GCAC #FUAPF #APP

[HighYieldStocks]

GCAC is one of these top pick-and-shovel companies is the cannabis tech startup GCAC (Global Cannabis Applications Corp., USA: FUAPF, Canada: APP).

The company just introduced the cannabis efficacy app Efixii App (which btw has potentially many other efficacy applications e.g. in the medical/pharma sector). For the first time, the efficacy and quality of cannabis products (mostly medical but also recreational) can be precisely measured now. The Efixii App was approved in record time and is available on both the Google Play Store and the Apple App Store. For each distributed gram, GCAC will earn CDN$0,38.

Based on its newest Investor update from a few days ago, the company is planning to participate with its Efixii App and 36 growers in the distribution of 128 million grams by 2023. This will result in a high-profit margin revenue (65% EBITDA) of approx. CDN$48.6 Million. ( https://cdn-ceo-ca.s3.amazonaws.com/1fu8u5t-GCAC-IR_Dec23+v10.1.pdf ).

Morningstar has an "undervalued" rating on GCAC (FUAPF/APP) and a fair-value price target of $0.20. Currently, shares of GCAC (FUAPF) trade just below $0.10 in the U.S. and at CDN$0.12 (APP) in Canada. Also due to its extremely low market cap of only approx. $15M, we think, IMO, that shares could rise to at least $0.50 to $1/share for an attractive basis and the company would be still valued at only a fraction of the initial Weedmaps/SSPK market cap. Long-term growth could be really astronomical with the company reaching a multi-billion dollar valuation. It can be expected that institutional investors will tap into the GCAC play (possibly perhaps via a buyout/merger) over time due to the phenomenal growth potential.

[HighYieldStocks]

Investordeck 12/2020 ... Yes, here's the new very exciting Investor Deck complete with all the details and explanations. Well worth the time to read it. We'll have that in circulation during the last few days of 2020 and right into the New Year!

https://cdn-ceo-ca.s3.amazonaws.com/1fu8u5t-GCAC-IR_Dec23+v10.1.pdf

[HighYieldStocks]

BUY SELL RATIO 71:1 and -7% ??? WTF ???

[HighYieldStocks]

Just needs VOLUME to run hard !!!!!

[HighYieldStocks]

GCAC (USA: FUAPF / Canada: APP) ... Today's Investor update is gigantic news regarding the powerful highly-profitable revenue model of the company

https://cannappscorp.com/2020/12/23/end-of-year-2020-investors-update/?fbclid=IwAR2dvfhj-9H2Dq8Rmf3e3d4B1K-N2NQ_sd0qhHaxlNhYASnljNQZF3-6E-o

This high-growth company with unique cannabis technology is leading the global marketplace. Compared to Weedmaps (SSPK merger coming) recent valuation of $1.5 Billion and GCAC's valuation of only approx. $15 Million (only 1% of Weedmaps valuation), it's obvious that GCAC has tremendous upward potential from the current US$0.09 to at least approx.

$1 in the not too distant future, IMO, based on their revenue model with their Efixii App (available in the Google Play Store and Apple App Store) and their Citizen Green universe. GCAC's technology will impact mostly mid-size growers, virtually all consumers and distributors, etc. as well as most other cannabis companies like CGC CRON ACB TLRY SNDL etc. on a global basis.

[HighYieldStocks]

Marketing and Sales Milestones

[HighYieldStocks]

BOOOOOOOMMMMM ... https://mobile.twitter.com/CitizenGreenWld

In what seems like record time, Apple has approved Efixii for the iOS AppStore, which completes our app's successful launch on all major platforms.
#blockchain #cannabis #cbd #cannabisbusiness #cannabiscommunity #cannabisindustry #medicalcannabis
https://t.co/L2gbWEVNDi https://t.co/T4emdpBwBM

[HighYieldStocks]

Looking strong, needs to keep going !!!!!

Morningstar rated FUAPF (USA ... Canada: APP ... Global Cannabis Applications Corp) "Undervalued" with a Fair Value of $0.20 saying that the company "has outperformed its Software & Programming peers over the last three month and over the past year."
FUAPF is extremely undervalued, IMO, and their revenue/profit model should be explained very soon as it's based on a share of the tens of millions of grams of Cannabis harvested, distributed, etc. On the upside we don't think that there's a better cannabis play out there, not only for trading (due to its volatility), but also for its long(er) term potential and seems to be much better than pure cannabis stocks like CRON CGC TLRY ACB SNDL etc., especially with the high valuation of $1.5 Billion for Weedmaps now, so FUAPF stock has much catch up to do as also Morningstar sees the company as "Undervalued" with much higher fair value as indicated.

[HighYieldStocks]

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

https://www.barchart.com/stocks/quotes/APP.CN?fbclid=IwAR3ig5FestZNwbpmkcpB-kvorGwh8caLDdNUTlY0JYyaG01f1wUSfXC8fH4

[HighYieldStocks]

Citizen Green Medical Cannabis Data-Acquisition Platform Goes Live with the Signing of a 3-Year SaaS Licensing Deal


Vancouver, British Columbia, Canada – TheNewswire - October 14, 2020 –

Global Cannabis Applications Corp. ("GCAC" or the "Company") (CSE:APP), (CNSX:APP.CN), (FSE:2FA), (OTC:FUAPF), a leading commercial licensor of proprietary Data and AI technologies to the medical cannabis industry, today announced a definitive three-year software licensing deal with Bless Cultivation Ltd. (“Bless”), an Israeli based medical cannabis cultivator. This licensing agreement marks GCAC first sales revenue for Citizen Green since announcing its launch on September 3, 2020.


https://www.thenewswire.com/press-releases/1ArbFxEy7-citizen-green-medical-cannabis-data-acquisition-platform-goes-live-with-the-signing-of-a-3-year-saas-licensing-deal.html

[HighYieldStocks]

App has outperformed its Software and Programmen peers

[HighYieldStocks]

Homepage ... http://www.cannappscorp.com

[HighYieldStocks]

Great news from Apple! The Efixii app is now available on the Mac App Store
Efixii helps producers, labs & retailers ensure the best outcome for their medical cannabis patients. https://apps.apple.com/us/app/efixii/id1541680191

[HighYieldStocks]

I think lots of great things are about to happen here in a very short period of time

[HighYieldStocks]

$FUAPF's Efixii app (a must for every cannabis patient/user, grower, doctor, distributor, dispensary, etc.) was just approved in record time by $GOOG $GOOGL and is now available in the Google Play Store https://play.google.com/store/apps/details?id=io.efixii.app. ...

Big game changer for the cannabis industry to bring quality, efficiency and legitimacy for the cannabis (medical and recreational) trade. All cannabis companies like $CGC $CRON ACB SNDL TLRY APHA etc. will all benefit from it. And FUAPF shares are set for a major move upward, IMO, their Efixii app is money in the bank with excellent technology and strong alliances behind it.

[HighYieldStocks]

Go and install the Efixxii app. Very clear and all functions that you need.

Great structure and very well thought out.
Can only congratulate $APP.C

[HighYieldStocks]

Dated but helpful

[HighYieldStocks]

$FUAPF exciting time for this little gem. This company also has crypto token based on Ethereum 2.0 as part of their rewards. With bitcoin at all time high can only bode well for fuapf. In addition, cannabis stocks will get much attention coming next year due to change in US government. Global Cannabis Application is at the right time , at right place to run towards dollar land.

Extremely undervalued

[HighYieldStocks]

Will add on any dips today. App Store news will circulate over the weekend setting us up for a big move soon imo. GL

[HighYieldStocks]

BUY SELL RATIO 8:1 ... weeeeeeeeee

[HighYieldStocks]

More from Brad via LinkedIn



"August 13, 2020-GCAC CEO, Brad Moore, was a keynote speak at the Pharma Connect Africa Conference Series. The conference was held via teleconferencing and joined by over 60 attendees. Moore spoke about the benefits of GCAC’s newest technology, Tracelocker. Tracelocker is uniquely suited to help growers meet the stringent compliance requirements mandated for the successful production and exportation of medical cannabis and CBD. Moore was joined by Darren Franceschini of Sprout CrowdFunding and the opportunities available to growers in Africa to participate
The inaugural PharmaConnect Africa Conference and Expo were first held on March 2017. PharmaConnect Africa has been considered a credible forum where role players in Africa pharma can meet and network. Conferences have included official representation from regulators (e.g. Ghana FDA, East Africa Community (EAC) and the home authority (South African Health Products – Regulatory Authority), Department of Health (South Africa), local manufacturers ,associations under the auspices of International Pharmaceutical Manufacturers’ Association (IFPMA), various South African universities, strategic partners and UN agencies (UNIDO and WHO),More information about PharmaConnect Africa:"

[HighYieldStocks]

Global Cannabis talks readiness to license 3T service

2020-08-12 06:43 ET - News Release

Mr. Bradley Moore reports
GCAC ANNOUNCES EXPANSION OF THE CITIZEN GREEN PLATFORM WITH NEW 3T ("TRACK-TRACE-TREAT") DATA SERVICE FOR MEDICAL CANNABIS GROWERS
Global Cannabis Applications Corp. is ready to commercially license its new 3T (track-trace-treat) data service following the signing of a sublicensing and integration memorandum of understanding with TraceLocker, an Ethereum blockchain compliance platform for medical cannabis growers and importers.
Licensing the Global Cannabis Applications's 3T data acquisition service opens immediate revenue opportunities for the company, starting from the earliest phase of a medical cannabis grower's journey. Following Global Cannabis Applications's successful test the waters campaign with actual growers, the 3T service offering was finalized and the company stands ready to offer 3T to the nascent medical cannabis industry.
Cannabis contains approximately 60 pharmacologically active compounds (cannabinoids) and it is the ratio in botanical and pharmaceutical preparations determines therapeutic versus psychoactive effects. Global Cannabis Applications's 3T immutably records every step in a plants life cycle prior to being administered as a treatment. It is this level of traceability that growers, practitioners and consumers require in order to accurately measure efficacy and to ensure product consistency.
Global Cannabis Applications's Citizen Green and TraceLocker blockchain data sets combine to identify the most efficient treatment per ailment per consumer inside the Global Cannabis Applications Prescriptii patient care solution.
"Based on our gap analysis, we identified an unmet demand for a turnkey, grower-aligned, track-trace-treat service. Expanding the Citizen Green suite by capturing data from the initial seed-planting phase adds significantly more firepower to GCAC's commercial data aggregation strategy. Secure storage of multiple cannabis data points on a blockchain is well documented in our patent filed December, 2019, and TraceLocker's Ethereum blockchain framework aligns perfectly with our vision," stated Brad Moore, Global Cannabis Applications's chief executive officer. "Per our recently released corporate communications presentation, early connectivity with growers is critical for GCAC's ownership of data through the medical cannabis value chain. This not only creates growth through sales of that data but also by providing those cannabis data sets to regulators to make informed, legal decisions about the importation and usage of medical cannabis as a treatment."
The parties agree to act in goodwill and, due to the complex nature of blockchain integration, agree to provide clear timelines for Global Cannabis Applications branding, technology deployments and grower support. Additionally, the parties jointly agree to participate in future commercial expansion strategies, further technical integration, testing, rollout and support. The new 3T solution will be Global Cannabis Applications branded and offered as part of the Citizen Green suite of technologies.
About Global Cannabis Applications Corp.
Global Cannabis is a global leader in designing, developing, marketing and acquiring innovative data technologies for the medical cannabis industry. The Citizen Green platform is the world's first end-to-end -- from patient to regulator -- medical cannabis data solution.

[HighYieldStocks]

GCAC Announces Commercial Launch of its $5.92m Medical Cannabis Data-Acquisition Platform

https://ceo.ca/@thenewswire/gcac-announces-commercial-launch-of-its-592m-medical?fbclid=IwAR1-bu8aHOmkEZpuR2mce996Gjuiv-DfV3-yTME8f5ElSVB0DV_wkb35KFM

[HighYieldStocks]

BULLS ARE IN FULL CONTROLL ... WE ARE GOLDEN HERE

[HighYieldStocks]

Pink Current Infomation

https://www.otcmarkets.com/stock/FUAPF/overview

[HighYieldStocks]

100% Buy with a Strongest short term outlook on maintaining the current direction.

https://www.barchart.com/stocks/quotes/APP.CN/overview

[HighYieldStocks]

$app $app.c $fuapf CEO Brad Moore.....”What an exciting day for GCAC as we sign up a great partner to use our newest Citizen Green Technology. Thanks to the team at Bless Cultivation as we all work to create better outcomes for medical cannabis patients.”

Citizen Green Medical Cannabis Data-Acquisition Platform Goes Live with the Signing of a 3-Year SaaS Licensing Deal

https://www.thenewswire.com/press-releases/1ArbFxEy7

[HighYieldStocks]

Global Cannabis Applications (APP.C) uses blockchain and your smartphone to authenticate your medical cannabis

https://equity.guru/2020/10/07/global-cannabis-applications-app-c-uses-blockchain-smartphone-authenticate-medical-cannabis/?fbclid=IwAR3HH6xrjSPdgVsXO28lGM8Koiag9YiqM8JGewPJ_oIzhIIiw-ToXWwth3Q